• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Transgenic mouse as a model of lipoprotein glomerulopathy (LPG), and analysis of LPG

Research Project

Project/Area Number 11671064
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionFukuoka University

Principal Investigator

MATSUNAGA Akira  School of Medicine, Fukuoka University, Assist.Prof., 医学部, 講師 (60221587)

Co-Investigator(Kenkyū-buntansha) SASAKI Jun  School of Medicine, Fukuoka University, Assoc.Prof., 医学部, 助教授 (90122697)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2000: ¥1,600,000 (Direct Cost: ¥1,600,000)
Fiscal Year 1999: ¥1,900,000 (Direct Cost: ¥1,900,000)
Keywordslipoprotein glomerulopathy / apo E / apolipoprotein / transgenic mouse / mutation
Research Abstract

Lipoprotein glomerulopathy (LPG) is a newly recognized renal disease in 1988. It is characterized by abnormal lipoprotein deposition in the marked dilated glomerular capillaries, and elevated plasma concentration of apolipoprotein (apo) E.Recently, we identified an apoE variant, apoE2 Sendai (Arg 145Pro) in three Japanese kindred with LPG.Furthermore, we discovered three different novel apoE variants, apo E2 Kyoto (Arg25Cys) apo E1 (del 141-143) and apo E1 (del 156-173), which are closely related to LPG.Establishment of an apo E 1 (del 141-143) transgenic mouse was tried as an animal model of LPG.ApoE1 (del 141-143) variant was introduced into normal apoE gene including promoter region (11.5kb) using site directed mutagenesis. Fragment of the variant human apoE gene digested with HindIII was purified and microinjected into pronuclei of fertilized eggs of C57BL/6 mice. Injected eggs were surgically transferred to oviducts of anesthetized surrogate females. However, the transgenic mice were killed because they were infected with pathogenic virus. Second microinjection was done, and seven pups were born. Genomic DNA was isolated from their tails. Polymerase chain reaction analysis was performed on genomic tail DNA using primer set of human apoE gene. Human apoE gene was detected from a female mouse. Human apoE gene detection rate of Fl mice was very low, and human apoE gene was confirmed currently in two male mice. After homozygotes of apoE1 (del 141-143) mice are established, analysis of their glomerulus lesions and serum lipoproteins are planned.

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] Huang W,Sasaki J,Matsunaga A, et al.: "A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction."Arterioscler Thromb Vasc Biol. 20. 210-216 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kobayashi J,Murano S,Yokote K,Mori S, Matsunaga A, et al.: "Marked decrease in plasma apolipoprotein A-I and high density lipoprotein-cholesterol in a case with Werner syndrome."Clinca Chimica Acta. 293. 63-73 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Imanaga Y,Sakata N,Takebayashi S,Matsunaga A, et al.: "In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques."Atherosclerosis. 150. 343-355 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hirayama S,Kobayashi J,Taira K,Hikita M,Bujo H,Matsunaga A,: "Marked elevation in serum apolipoprotein E in a case of heterozygous cholesteryl ester transfer protein deficiency."Clinca Chimica Acta. 301. 55-64 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Huang W, Sasaki J, Matsunaga A, Han H, Li W, Koga T, Kugi M, Ando S, Arakawa K: "A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction."Arterioscter Thromb Vase Biol. 20. 210-216 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kobayashi J, Murano S, Yokote K, Mori S, Matsunaga A, Sasaki J, Takahashi K, Bujo H, Saito Y: "Marked decrease in plasma apolipoprotein A-I and high density lipoprotein-cholesterol in a case with Werner syndrome."Clinca Chimica Acta. 293. 63-73 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Imanaga Y, Sakata N, Takebayashi S, Matsunaga A, Sasaki J, Arakawa K, Nagai R, Horiuchi S.Itabe H, Takano T: "In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques."Atherosclerosis. 150. 343-355 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hirayama S, Kobayashi J, Taira K, Hikita M, Bujo H, Morisaki N, Matsunaga A, Sasaki J, Saito Y: "Marked elevation in serum apolipoprotein E in a case of heterozygous cholesteryl ester transfer protein deficiency."Clin Chim Acta. 301. 55-64 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Huang W,Sasaki J,Matsunaga A, et al.: "A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction."Arterioscler Thromb Vasc Biol. 20. 210-216 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Kobayashi J,Murano S,Yokote K,Mori S,Matsunaga A, et al.: "Marked decrease in plasma apolipoprotein A-I and high density lipoprotein-cholesterol in a case with Werner syndrome."Clinca Chimica Acta. 29.3. 63-73 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Imanaga Y,Sakata N,Takebayashi S,Matsunaga A, et al.: "In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques."Atherosclerosis. 150. 343-355 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Hirayama S,Kobayashi J,Taira K,Hikita M,Bujo H,Matsunaga A, et al.: "Marked elevation in serum apolipoprotein E in a case of heterozygous cholesteryl ester transfer protein deficiency."Clinca Chimica Acta. 301. 55-64 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Matsunaga A,et al.: "Compound heterozygosity for an apolipoprotein A1 gene promoter mutation and structural nonsense mmutation with apolipoprotein A1 deficiency."Arterioscler Thromb Vasc Biol. 19. 348-355 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Han H,Sasaki J,Matsunaga A,et al.: "A novel mutant,ApoA-I Nichinan(Glu235→0),is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells."Arterioscler Thromb Vasc Biol. 19. 1447-1455 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Matsunaga A,et al.: "A novel apolipoprotein E mutation,E2(Arg25Cys) in lipoprotein glomerulopathy."Kidney International. 56. 421-427 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ando M,Sasaki J,Han H,Matsunaga A,et al.: "A novel I8-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy."Kidney International. 56. 1317-1323 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Konishi K,et al.: "Association of a novel 3-amino acid deletion mutation of a polipoprotein E(apo E Tokyo) with lipoprotein glomerulopathy."Nephron. 83. 214-218 (1999)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi